Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock () or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.





Protecting Public Health and Safety

Predatory and illegal intellectual property (IP) trade practices affect every aspect of our lives. The National Intellectual Property Rights Coordination Center (IPR Center) leads the U.S. government's response to stop global IP theft and enforce trade laws.

Comprised of federal agencies and industry experts, the IPR Center develops initiatives, coordinates enforcement actions and shares information related to intellectual property (IP) theft. It also stops predatory, illegal trade practices that threaten the public's health and safety, the U.S. economy and national security.

Learn More


By the Numbers

IP theft is not a victimless crime. Victims are American consumers, businesses, trademark holders and people who manufacture and sell legitimate products. Often, the illicit proceeds resulting from the sale of counterfeit or unlicensed products are funneled back to support a broad range of illegal crimes. Every day, the IPR Center works with industries and agencies to stop IP theft that threatens U.S. businesses, robs hardworking Americans of their jobs and negatively impacts the economy. From criminal arrests to the seizure of goods, the numbers tell the story.

Criminals sell pirated merchandise and counterfeit U.S. products around the globe. And, while it seems harmless to buy a knock-off purse, an inexpensive electronic device or cheaper medication, these trade practices threaten the public's health and safety, the U.S. economy and national security by introducing harmful and banned materials into counterfeit products and supporting illegal labor practices. The U.S. government created the IPR Center to stop predatory and illegal trade practices.

By bringing together domestic and international government agencies and private industry partners, the IPR Center presents a unified force to combat global intellectual property theft and enforce IP rights violations. The IPR Center was established to combat global IP theft and, accordingly, has a significant role policing the sale and distribution of counterfeit goods on websites, social media, and the dark web.


IP PROTECT

Learn how IP Project can help small businesses protect themselves from intellectual property theft, fraud and cyber-attacks.

If you represent a small business or organization wanting to learn more about IP Protect, please click on the button below.

More Information


RECENT NEWS

2024/09/23 15:29:00 UTC

Automotive Safety Awareness Campaign Warns Consumers About Counterfeit Airbags

WASHINGTON — Vehicle owners and drivers across the country should be on high alert for unsafe and potentially deadly counterfeit auto parts as the National Intellectual Property Rights Coordination Center (IPR Center) launches its new campaign, “Put the Brakes on Fakes.”

Read Article →

2024/09/04 11:24:00 UTC

IPR Center Announces New Director

WASHINGTON– Homeland Security Investigations (HSI) Executive Associate Director Katrina W. Berger has announced that Ivan J. Arvelo has been appointed as the new Director of the National Intellectual Property Rights Coordination Center (IPR Center). The IPR Center, which stands at the forefront of the U.S. government's response to global intellectual property theft and trade law enforcement, collaborates with federal agencies, international law enforcement, academia, and private sector partners.

Read Article →

2024/07/25 12:15:00 UTC

Foreign National Charged for Selling Counterfeit Cancer Drugs

A federal grand jury in Houston has returned a significant indictment against an Indian national accused of trafficking counterfeit oncology pharmaceuticals into the U.S. Charged with one count of conspiracy and four counts of trafficking, the individual faces up to 20 years in prison per count if convicted. This case highlights the ongoing efforts to combat counterfeit drugs and protect patient safety.

Read Article →

See All News

**The appearance of any non-federal entities and/or reference to vendors does not constitute, imply, or infer endorsement or sanction of their products or services by the IPR Center, DHS, or the federal government.